Changes
On October 25, 2024 at 12:23:22 PM UTC, Edoardo Luca Vigano:
-
No fields were updated. See the metadata diff for more details.
f | 1 | { | f | 1 | { |
2 | "age_type": [], | 2 | "age_type": [], | ||
3 | "author": "Edoardo Luca Vigan\u00f2", | 3 | "author": "Edoardo Luca Vigan\u00f2", | ||
4 | "author_email": "edoardo.vigano@marionegri.it", | 4 | "author_email": "edoardo.vigano@marionegri.it", | ||
5 | "category": [], | 5 | "category": [], | ||
6 | "cells_number": "", | 6 | "cells_number": "", | ||
7 | "content": [], | 7 | "content": [], | ||
8 | "creator_user_id": "56153fff-4293-4f39-9723-fcc904de812a", | 8 | "creator_user_id": "56153fff-4293-4f39-9723-fcc904de812a", | ||
9 | "culture_medium": [], | 9 | "culture_medium": [], | ||
10 | "dimension": [], | 10 | "dimension": [], | ||
11 | "experiment_date": "", | 11 | "experiment_date": "", | ||
12 | "groups": [], | 12 | "groups": [], | ||
13 | "id": "011fac9e-86c9-44d5-b5f9-96cfaa15ce06", | 13 | "id": "011fac9e-86c9-44d5-b5f9-96cfaa15ce06", | ||
14 | "isopen": false, | 14 | "isopen": false, | ||
15 | "license_id": "", | 15 | "license_id": "", | ||
16 | "license_title": "", | 16 | "license_title": "", | ||
17 | "maintainer": "", | 17 | "maintainer": "", | ||
18 | "maintainer_email": "", | 18 | "maintainer_email": "", | ||
19 | "metadata_created": "2024-10-25T12:21:33.884724", | 19 | "metadata_created": "2024-10-25T12:21:33.884724", | ||
n | 20 | "metadata_modified": "2024-10-25T12:23:13.969762", | n | 20 | "metadata_modified": "2024-10-25T12:23:21.996202", |
21 | "model": [], | 21 | "model": [], | ||
22 | "name": "increase-mitochondrial-dysfunction-cddd2", | 22 | "name": "increase-mitochondrial-dysfunction-cddd2", | ||
23 | "notes": "Increase Mitochondrial Dysfunction\r\n\r\nIn accordance | 23 | "notes": "Increase Mitochondrial Dysfunction\r\n\r\nIn accordance | ||
24 | with the events outlined in the linear AOP framework for | 24 | with the events outlined in the linear AOP framework for | ||
25 | cardiotoxicity developed in the ALTERNATIVE project, we collected data | 25 | cardiotoxicity developed in the ALTERNATIVE project, we collected data | ||
26 | from biological assays providing information on the potential toxic | 26 | from biological assays providing information on the potential toxic | ||
27 | interactions between chemicals and specific biological targets. In | 27 | interactions between chemicals and specific biological targets. In | ||
28 | this case the endpoint under consideration in the Mitochondrial | 28 | this case the endpoint under consideration in the Mitochondrial | ||
29 | Dysfunction.\r\n\r\nBinary Endpoint.\r\n\r\nList of the assays | 29 | Dysfunction.\r\n\r\nBinary Endpoint.\r\n\r\nList of the assays | ||
30 | considered for evaluate mitochondrial dysfunction activity:\r\nAPR | 30 | considered for evaluate mitochondrial dysfunction activity:\r\nAPR | ||
31 | HepG2 MitoMass 24 h dn, APR HepG2 MitoMass 24 h up, APR HepG2 MitoMass | 31 | HepG2 MitoMass 24 h dn, APR HepG2 MitoMass 24 h up, APR HepG2 MitoMass | ||
32 | 72 h dn, APR HepG2 MitoMass 72 h up, APR HepG2 MitoMembPot 24 h dn, | 32 | 72 h dn, APR HepG2 MitoMass 72 h up, APR HepG2 MitoMembPot 24 h dn, | ||
33 | APR HepG2 MitoMembPot 24 h up, APR HepG2 MitoMembPot 72 h dn, APR | 33 | APR HepG2 MitoMembPot 24 h up, APR HepG2 MitoMembPot 72 h dn, APR | ||
34 | HepG2 MitoMembPot 72 h up, ATG XTT Cytotoxicity up, TOX21 MMP ratio | 34 | HepG2 MitoMembPot 72 h up, ATG XTT Cytotoxicity up, TOX21 MMP ratio | ||
35 | down, TOX21 MMP ratio up, TOX21 MMP rhodamine\r\n\r\nAOP source: | 35 | down, TOX21 MMP ratio up, TOX21 MMP rhodamine\r\n\r\nAOP source: | ||
36 | https://aopwiki.org/events/177\r\n\r\nData curation and data source: | 36 | https://aopwiki.org/events/177\r\n\r\nData curation and data source: | ||
37 | https://doi.org/10.3390/toxics12010087 ", | 37 | https://doi.org/10.3390/toxics12010087 ", | ||
38 | "num_resources": 1, | 38 | "num_resources": 1, | ||
39 | "num_tags": 2, | 39 | "num_tags": 2, | ||
40 | "organization": { | 40 | "organization": { | ||
41 | "approval_status": "approved", | 41 | "approval_status": "approved", | ||
42 | "created": "2023-03-17T17:42:44.917090", | 42 | "created": "2023-03-17T17:42:44.917090", | ||
43 | "description": "The Mario Negri Institute for Pharmacological | 43 | "description": "The Mario Negri Institute for Pharmacological | ||
44 | Research (www.marionegri.it) is a not-for-profit | 44 | Research (www.marionegri.it) is a not-for-profit | ||
45 | biomedical\r\nresearch organization.\r\nIt was established in Milan in | 45 | biomedical\r\nresearch organization.\r\nIt was established in Milan in | ||
46 | 1961 and later (1984) opened research units in Bergamo, currently | 46 | 1961 and later (1984) opened research units in Bergamo, currently | ||
47 | located at the\r\nKilometro Rosso Science and Technology Park, and | 47 | located at the\r\nKilometro Rosso Science and Technology Park, and | ||
48 | Ranica (near Bergamo)", | 48 | Ranica (near Bergamo)", | ||
49 | "id": "e50db934-20d8-4a27-80a2-ce67bc4d99db", | 49 | "id": "e50db934-20d8-4a27-80a2-ce67bc4d99db", | ||
50 | "image_url": "2023-03-17-174244.890524IMNOrizzontaleRGB.png", | 50 | "image_url": "2023-03-17-174244.890524IMNOrizzontaleRGB.png", | ||
51 | "is_organization": true, | 51 | "is_organization": true, | ||
52 | "name": "irfmn", | 52 | "name": "irfmn", | ||
53 | "state": "active", | 53 | "state": "active", | ||
54 | "title": "IRFMN", | 54 | "title": "IRFMN", | ||
55 | "type": "organization" | 55 | "type": "organization" | ||
56 | }, | 56 | }, | ||
57 | "owner_org": "e50db934-20d8-4a27-80a2-ce67bc4d99db", | 57 | "owner_org": "e50db934-20d8-4a27-80a2-ce67bc4d99db", | ||
58 | "private": false, | 58 | "private": false, | ||
59 | "ratio_hipsccms_hcaecs": "", | 59 | "ratio_hipsccms_hcaecs": "", | ||
60 | "relationships_as_object": [], | 60 | "relationships_as_object": [], | ||
61 | "relationships_as_subject": [], | 61 | "relationships_as_subject": [], | ||
62 | "replicates_number": "", | 62 | "replicates_number": "", | ||
63 | "resources": [ | 63 | "resources": [ | ||
64 | { | 64 | { | ||
65 | "cache_last_updated": null, | 65 | "cache_last_updated": null, | ||
66 | "cache_url": null, | 66 | "cache_url": null, | ||
67 | "created": "2024-10-25T12:23:14.036860", | 67 | "created": "2024-10-25T12:23:14.036860", | ||
68 | "datastore_active": false, | 68 | "datastore_active": false, | ||
69 | "description": "QSAR ready database for Mitochondrial | 69 | "description": "QSAR ready database for Mitochondrial | ||
70 | Dysfunction toxicity.\r\n\r\nlabels: binary endpoint {0: inactive, 1: | 70 | Dysfunction toxicity.\r\n\r\nlabels: binary endpoint {0: inactive, 1: | ||
71 | active}", | 71 | active}", | ||
72 | "format": "CSV", | 72 | "format": "CSV", | ||
73 | "hash": "", | 73 | "hash": "", | ||
74 | "id": "6d822a80-fcef-4625-8e78-4873528f6f0a", | 74 | "id": "6d822a80-fcef-4625-8e78-4873528f6f0a", | ||
75 | "last_modified": "2024-10-25T12:23:13.946675", | 75 | "last_modified": "2024-10-25T12:23:13.946675", | ||
n | 76 | "metadata_modified": "2024-10-25T12:23:13.978248", | n | 76 | "metadata_modified": "2024-10-25T12:23:22.035423", |
77 | "mimetype": null, | 77 | "mimetype": null, | ||
78 | "mimetype_inner": null, | 78 | "mimetype_inner": null, | ||
79 | "name": "Increase_mitochondrial_dysfunction_dataset_CDDD.csv", | 79 | "name": "Increase_mitochondrial_dysfunction_dataset_CDDD.csv", | ||
80 | "package_id": "011fac9e-86c9-44d5-b5f9-96cfaa15ce06", | 80 | "package_id": "011fac9e-86c9-44d5-b5f9-96cfaa15ce06", | ||
81 | "position": 0, | 81 | "position": 0, | ||
82 | "resource_type": null, | 82 | "resource_type": null, | ||
83 | "size": 28932502, | 83 | "size": 28932502, | ||
84 | "state": "active", | 84 | "state": "active", | ||
85 | "url": | 85 | "url": | ||
86 | 28f6f0a/download/increase_mitochondrial_dysfunction_dataset_cddd.csv", | 86 | 28f6f0a/download/increase_mitochondrial_dysfunction_dataset_cddd.csv", | ||
87 | "url_type": "upload" | 87 | "url_type": "upload" | ||
88 | } | 88 | } | ||
89 | ], | 89 | ], | ||
90 | "size": 28932502, | 90 | "size": 28932502, | ||
t | 91 | "state": "draft", | t | 91 | "state": "active", |
92 | "tags": [ | 92 | "tags": [ | ||
93 | { | 93 | { | ||
94 | "display_name": "Mitochondrial dysfunction", | 94 | "display_name": "Mitochondrial dysfunction", | ||
95 | "id": "b6ac39d6-dd68-4012-81ad-3dbf4f6a90b3", | 95 | "id": "b6ac39d6-dd68-4012-81ad-3dbf4f6a90b3", | ||
96 | "name": "Mitochondrial dysfunction", | 96 | "name": "Mitochondrial dysfunction", | ||
97 | "state": "active", | 97 | "state": "active", | ||
98 | "vocabulary_id": null | 98 | "vocabulary_id": null | ||
99 | }, | 99 | }, | ||
100 | { | 100 | { | ||
101 | "display_name": "cardiotoxicity", | 101 | "display_name": "cardiotoxicity", | ||
102 | "id": "8ba178e0-bd1e-46ad-aa0b-a1e1c430545b", | 102 | "id": "8ba178e0-bd1e-46ad-aa0b-a1e1c430545b", | ||
103 | "name": "cardiotoxicity", | 103 | "name": "cardiotoxicity", | ||
104 | "state": "active", | 104 | "state": "active", | ||
105 | "vocabulary_id": null | 105 | "vocabulary_id": null | ||
106 | } | 106 | } | ||
107 | ], | 107 | ], | ||
108 | "title": "Increase Mitochondrial Dysfunction", | 108 | "title": "Increase Mitochondrial Dysfunction", | ||
109 | "toxin": [], | 109 | "toxin": [], | ||
110 | "type": "dataset", | 110 | "type": "dataset", | ||
111 | "url": "", | 111 | "url": "", | ||
112 | "version": "0.2" | 112 | "version": "0.2" | ||
113 | } | 113 | } |